Related News
Americans overpaying for cancer drugs
Print Edition
Americans are paying way over the odds for some modern cancer drugs, with pharmaceutical companies charging up to 600 times what the medicines cost to make, according to an independent academic study.
The United States also pays more than double the price charged in Europe for these drugs 鈥 so-called tyrosine kinase inhibitors, a potent class of cancer pills with fewer side effects than chemotherapy.
The analysis by pharmacologist Andrew Hill of Britain鈥檚 University of Liverpool, who will present his findings at the European Cancer Congress in Vienna, is likely to fuel a growing storm over US drug costs.
Democratic presidential candidate Hillary Clinton鈥檚 declared aim to lower the cost of prescription drugs by ending what she describes as 鈥渆xcessive profiteering鈥 triggered a sell-off in drug stocks this week.
Hill said he had shared his work on the cost of producing TKIs with the World Health Organization, which is keen to add such treatments to its list of medicines deemed essential for a basic healthcare system.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
